Esperion Therapeutics, Inc. (ESPR) Forms $75.06 Double Top; S&T Bank Cut Its Amtrust Financial Services (AFSI) Position

Esperion Therapeutics, Inc. (ESPR) formed double top with $81.06 target or 8.00% above today’s $75.06 share price. Esperion Therapeutics, Inc. (ESPR) has $1.99B valuation. The stock decreased 3.70% or $2.88 during the last trading session, reaching $75.06. About 815,730 shares traded or 40.22% up from the average. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 133.75% since March 7, 2017 and is uptrending. It has outperformed by 117.05% the S&P500.

S&T Bank decreased Amtrust Financial Services (AFSI) stake by 7.75% reported in 2017Q3 SEC filing. S&T Bank sold 35,251 shares as Amtrust Financial Services (AFSI)’s stock declined 55.63%. The S&T Bank holds 419,308 shares with $5.64M value, down from 454,559 last quarter. Amtrust Financial Services now has $2.51B valuation. The stock increased 0.12% or $0.015 during the last trading session, reaching $12.785. About 369,483 shares traded. AmTrust Financial Services, Inc. (NASDAQ:AFSI) has declined 53.49% since March 7, 2017 and is downtrending. It has underperformed by 70.19% the S&P500.

Investors sentiment decreased to 1.33 in 2017 Q3. Its down 0.34, from 1.67 in 2017Q2. It is negative, as 11 investors sold Esperion Therapeutics, Inc. shares while 34 reduced holdings. 30 funds opened positions while 45 raised stakes. 22.73 million shares or 17.55% more from 19.33 million shares in 2017Q2 were reported. Stifel has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 9,092 shares. J Goldman And Lp holds 0.08% or 30,020 shares in its portfolio. Pentwater Capital Management Ltd Partnership has 0.96% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 2.24 million shares. Employees Retirement Of Ohio invested in 0.01% or 29,555 shares. Wellington Mgmt Group Limited Liability Partnership has invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Pictet Asset Management Limited holds 0.04% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 306,455 shares. Gam Holdg Ag owns 225,000 shares. Gsa Capital Prtnrs Limited Liability Partnership reported 9,050 shares. Credit Agricole S A has 0.03% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 157,900 shares. Quantbot Technologies L P has 721 shares. Pinnacle Associates Ltd accumulated 717,813 shares. Moreover, Atika Limited Liability has 0.2% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Millennium Lc invested in 0% or 33,367 shares. Rothschild Asset Mngmt Incorporated invested in 0.01% or 22,425 shares. Sabby Mngmt Limited Liability holds 83,357 shares or 0.27% of its portfolio.

Among 18 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 10 have Buy rating, 0 Sell and 8 Hold. Therefore 56% are positive. Esperion Therapeutics has $130.0 highest and $10 lowest target. $59’s average target is -21.40% below currents $75.06 stock price. Esperion Therapeutics had 56 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Credit Suisse given on Monday, March 20. Citigroup maintained Esperion Therapeutics, Inc. (NASDAQ:ESPR) rating on Wednesday, June 29. Citigroup has “Buy” rating and $22 target. As per Tuesday, October 3, the company rating was maintained by Northland Capital. As per Wednesday, March 9, the company rating was maintained by JMP Securities. Stifel Nicolaus maintained Esperion Therapeutics, Inc. (NASDAQ:ESPR) rating on Thursday, February 25. Stifel Nicolaus has “Buy” rating and $64 target. Cowen & Co initiated the stock with “Buy” rating in Thursday, September 7 report. Zacks downgraded the stock to “Hold” rating in Friday, September 4 report. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) earned “Outperform” rating by RBC Capital Markets on Friday, November 6. The rating was maintained by JP Morgan on Wednesday, February 21 with “Neutral”. The stock has “Outperform” rating by RBC Capital Markets on Tuesday, December 15.

Investors sentiment increased to 0.92 in 2017 Q3. Its up 0.24, from 0.68 in 2017Q2. It improved, as 31 investors sold AFSI shares while 56 reduced holdings. 27 funds opened positions while 32 raised stakes. 65.41 million shares or 8.26% less from 71.30 million shares in 2017Q2 were reported. Vanguard Grp Inc holds 0.01% or 9.84M shares in its portfolio. Arcadia Investment Mngmt Corp Mi holds 25,850 shares. Jefferies Ltd Liability Corp reported 0.01% of its portfolio in AmTrust Financial Services, Inc. (NASDAQ:AFSI). Fmr Ltd Liability Co owns 87,900 shares or 0% of their US portfolio. Sei Comm accumulated 4,625 shares. Manufacturers Life Ins The owns 68,540 shares. Victory Capital Mngmt reported 0% of its portfolio in AmTrust Financial Services, Inc. (NASDAQ:AFSI). Elk Creek Ptnrs Limited Com reported 0.19% stake. Horizon Kinetics Limited Liability Company accumulated 35,595 shares or 0.01% of the stock. Ameriprise holds 0% in AmTrust Financial Services, Inc. (NASDAQ:AFSI) or 330,230 shares. Morgan Stanley invested in 329,927 shares or 0% of the stock. Navellier & reported 0.03% of its portfolio in AmTrust Financial Services, Inc. (NASDAQ:AFSI). Dimensional Fund Lp holds 2.70M shares. Rhumbline Advisers, Massachusetts-based fund reported 153,910 shares. Swiss Financial Bank invested in 140,480 shares.

Among 8 analysts covering Amtrust Financial Services (NASDAQ:AFSI), 3 have Buy rating, 0 Sell and 5 Hold. Therefore 38% are positive. Amtrust Financial Services had 24 analyst reports since August 5, 2015 according to SRatingsIntel. As per Monday, June 5, the company rating was maintained by Keefe Bruyette & Woods. The rating was upgraded by Compass Point on Friday, November 13 to “Buy”. The firm earned “Hold” rating on Tuesday, October 24 by FBR Capital. The company was downgraded on Wednesday, August 5 by Compass Point. The firm has “Buy” rating by Compass Point given on Thursday, February 11. The stock of AmTrust Financial Services, Inc. (NASDAQ:AFSI) earned “Market Perform” rating by JMP Securities on Monday, November 13. The firm has “Buy” rating given on Monday, October 23 by SunTrust. Compass Point downgraded the stock to “Hold” rating in Monday, February 26 report. Compass Point maintained the shares of AFSI in report on Friday, February 5 with “Buy” rating. The stock has “Hold” rating by Keefe Bruyette & Woods on Sunday, January 21.